Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TCRR | RVPH | MURA | ||
| Company | Tcr2 Therapeutics Inc | Reviva Pharmaceuticals Hldg Inc | Mural Oncology Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.5800 | 1.7000 | 3.37 | ||
| High | 1.6300 | 1.8399 | 3.37 | ||
| Low | 1.4800 | 1.5400 | 3.19 | ||
| Last | 1.4800 | 1.7800 | 3.24 | ||
| Change | -0.0900 | +0.1400 | -0.05 | ||
| % Change | -5.73% | +8.54% | -1.52% | ||
| Volume | 3,913,300 | 4,269,700 | 117,800 | ||
| 20-Day Average Volume | 474,175 | 5,118,870 | 205,360 | ||
| Previous Close | 1.5700 | 1.6400 | 3.29 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8315 | 1.7218 | 3.71 | ||
| 20-Day Raw Stochastic | 0.00% | 21.75% | 27.82% | ||
| 20-Day Relative Strength | 35.83% | 53.75% | 40.86% | ||
| Weighted Alpha | -29.20 | -57.11 | -39.96 | ||
| Today's Opinion | 8% Buy | 64% Buy | 8% Sell | ||
| Previous Opinion | 24% Buy | 16% Buy | 8% Sell | ||
| Last Month's Opinion | 56% Buy | 48% Sell | 16% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.45% since 05/23/23 | +27.14% since 12/17/24 | -4.42% since 12/17/24 | ||
| Low | 1.4800 on 05/31/23 | 1.2300 on 12/20/24 | 2.87 on 12/19/24 | ||
| High | 1.7800 on 05/24/23 | 1.8399 on 12/24/24 | 3.57 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | -16.15% since 04/28/23 | +56.14% since 11/22/24 | -3.28% since 11/22/24 | ||
| Low | 1.4800 on 05/31/23 | 1.0850 on 11/26/24 | 2.87 on 12/19/24 | ||
| High | 2.0400 on 05/08/23 | 4.2800 on 12/09/24 | 4.26 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +18.40% since 02/28/23 | +39.06% since 09/24/24 | +1.25% since 09/24/24 | ||
| Low | 1.1521 on 03/03/23 | 0.8820 on 11/11/24 | 2.87 on 12/19/24 | ||
| High | 2.0400 on 05/08/23 | 4.2800 on 12/09/24 | 4.26 on 11/25/24 | ||
| 6-Month | |||||
| %Chg | +13.85% since 11/28/22 | +39.06% since 06/24/24 | +0.62% since 06/24/24 | ||
| Low | 0.8210 on 12/23/22 | 0.6000 on 08/16/24 | 2.87 on 12/19/24 | ||
| High | 2.0400 on 05/08/23 | 4.2800 on 12/09/24 | 4.26 on 11/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 58,108 | 59,525 | 55,145 | ||
| Shares Outstanding, K | 39,262 | 33,441 | 17,020 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -151,820,000 | -39,260,000 | -207,450,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -40,400,000 | -8,370,000 | -31,760,000 | ||
| 60-Month Beta | 1.94 | -0.02 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 05/11/23 | -0.25 on 11/14/24 | -1.87 on 11/13/24 | ||
| Latest Earnings Date | 05/11/23 | 11/12/24 | 12/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||